Healthcare

GloGlo

Website
Founded 2024Origin source ↗Checked 2026-09-15

Overview

Our mission: eradicate type 1 diabetes.

GloGlo is building an AI-native therapeutics company focused on accelerating the discovery of treatments that can prevent, stop, and ultimately cure type 1 diabetes.

We are developing AI research agents that continuously analyze scientific literature and biological datasets, generate and challenge hypotheses, design experiments, and run them in a wet lab to learn from experimental results.

We are building a tight "in silico <> in vitro/vivo" feedback loop that helps us identify better targets, run experiments more efficiently, and move faster toward therapies for type 1 diabetes.

Company description As recorded 2026-11-08

Founders & team

Previously Markprompt, 14.ai

Company history As recorded 2026-11-08

Michael Fester

Founder

Co-founder GloGlo.com. Previously, co-founder of Snips (AI voice platform, acquired by Sonos). Maths at Cambridge.

Founder profile As recorded 2026-09-15
3team members reported
Source-reported As recorded 2026-09-15

Founded 2024 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthenriched profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The homepage contains prelaunch or closure language; availability needs review.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding yearrecent publishing observed